Skip to content

Clinical trials

Pulmonary Eosinophilia trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Eosinophilia Country / region: France Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20113
20142
20163
20181
20191
20202
20213
20221
20234
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting2
Terminated2
Unknown status2
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
GlaxoSmithKline4
Teva Branded Pharmaceutical Products R&D, Inc.3
Hospices Civils de Lyon2
University Hospital, Lille2
Areteia Therapeutics1
Assistance Publique - Hôpitaux de Paris1
GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc.1
Nantes University Hospital1
University Hospital, Grenoble1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Eosinophilia21
Asthma14
Dyspnea1
Nasal Polyps1
Rhabdomyolysis1

Trials

Showing 76 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.